Erythromycin, Zinc

Zineryt 40 MG/ML + 12 MG/ML Polvo y Disolvente Para Solucion Cutanea

40,0 mg + 12,0 mg solución cutáneaSpainWithdrawnAuthorised 14 Dec 2017

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
ZINERYT 40 MG/ML + 12 MG/ML POLVO Y DISOLVENTE PARA SOLUCION CUTANEA , 1 frasco de 30 ml	720049
ZINERYT 40 MG/ML + 12 MG/ML POLVO Y DISOLVENTE PARA SOLUCION CUTANEA , 1 frasco de 70 ml	720050

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Erythromycin, Zinc

Zineryt 40 MG/ML + 12 MG/ML Polvo y Disolvente Para Solucion Cutanea

40,0 mg + 12,0 mg solución cutáneaSpainWithdrawnAuthorised 14 Dec 2017

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
ZINERYT 40 MG/ML + 12 MG/ML POLVO Y DISOLVENTE PARA SOLUCION CUTANEA , 1 frasco de 30 ml	720049
ZINERYT 40 MG/ML + 12 MG/ML POLVO Y DISOLVENTE PARA SOLUCION CUTANEA , 1 frasco de 70 ml	720050

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Erythromycin, Zinc
Strength: 40,0 mg + 12,0 mg
Dosage form: solución cutánea
Route: uso cutáneo
Register: Spain (AEMPS)
Status: Withdrawn
Status in the register: Revocado
Authorised: 14 Dec 2017
Registration: 46-2002-89-C
Marketing authorisation holder: Astellas Pharma S.R.O.
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica